What's more, it addresses the FDA’s communications Using the applicant, the retention of data that assistance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may well transfer possession of the SE report back to a new applicant and Digital submission on the SE report and amend